Daily Intel -- 2026-04-29
Table of Contents
Top signal: FOMC holds 3.50-3.75% as expected -- Powell's final meeting statement flags "elevated inflation uncertainty" from energy shocks. Brent surges to $114.64 (+2.7%) as UAE announces OPEC exit effective May 1, stripping cartel of its third-largest producer. Sulfuric acid ban T-1. GOOGL/MSFT report after close -- Street expects GOOGL $106.9B (+19%), MSFT $81.3B Azure 37-38%. Rocket Lab wins $190M DoD hypersonic contract. NRC Part 53 (advanced reactor licensing) effective today. SiPh Day 19 stabilizing post-POET. RVMD new 52w high $155.70. ONDS best month of 2026 (+16%) on Mistral merger.
Key Signals
| # | Signal | Source | Tickers | Status | Confidence |
|---|---|---|---|---|---|
| 1 | Hormuz Day 16 -- UAE quits OPEC, Brent $114.64: UAE will leave OPEC and OPEC+ effective May 1, ending 60 years of membership. Frees UAE spare capacity (~1.5M bpd) post-crisis. Brent surged to $114.64 (+2.7%). Trump "unlikely" to accept Iran's latest proposal. 30-country Hormuz safeguard coalition forming. IEA: largest supply disruption on record. | WaPo, CNN, NPR, Al Jazeera | BTU (+), LEU (+), OKLO (+), IREN (-cost) | UPDATE (Day 16) | Very High |
| [VERIFIED -- UAE OPEC exit May 1 confirmed by CNN, CNBC, Al Jazeera, WaPo, Bloomberg. Brent $114.64 confirmed by TradingEconomics (+3.04%). NPR says "nearly 60 years" not exactly 60. IEA supply disruption characterization confirmed.] | |||||
| 2 | FOMC holds -- Powell's farewell flags inflation risk: Fed held at 3.50-3.75% as expected (100%). Statement flags "elevated uncertainty" on inflation from energy prices. CPI accelerated to 3.3% YoY in March (highest since May 2024). Warsh confirmation at 99% on Kalshi. June cut only 8%. Powell's last meeting before May 15 departure. | Fed, Kiplinger, CME FedWatch | All rate-sensitive | UPDATE | Very High |
| [VERIFIED -- Fed hold at 3.50-3.75% confirmed (Fed, CNBC, CBS, NPR). CPI 3.3% YoY March confirmed by BLS/CNBC. Powell's term ends May 15 confirmed. Warsh Senate Banking Committee vote Apr 29 confirmed. Polymarket 99.3% no-change confirmed.] | |||||
| 3 | Sulfuric acid ban T-1 (May 1): China export ban effective tomorrow. Double squeeze: Hormuz sulfur + China acid = global supply crisis. Sulfuric acid is foundational: 60% fertilizer, plus copper extraction, uranium leaching, semiconductor-grade acid. Chile/DRC/Zambia face acute copper processing disruption. Pentagon rare earth magnet timelines delayed 18-24 months. | Bloomberg, S&P Global, Mining.com | MP (+), LEU (+), AEHR/TSEM/AMKR (risk) | UPDATE (Day 19) | Very High |
| [VERIFIED -- China sulfuric acid export ban May 1 confirmed by Bloomberg, S&P Global, Mining.com, SCMP. 60% fertilizer use confirmed. Chile/Indonesia squeeze confirmed by S&P Global. Pentagon delay figure not independently corroborated but consistent with S&P analysis.] | |||||
| 4 | SiPh Day 19 -- stabilizing post-POET: POET recovered to $8.03 (+1%) after -47% crash. SiPh cluster stabilizing: LITE -7.9% ($791), COHR -5.5% ($304), TSEM -5.1% ($194), AAOI -5.8% ($137). Sympathy pullbacks creating entry opportunities -- fundamentals unchanged. EML laser 40-60% shortfall, OCI Alliance intact, backlog to 2028. Soitec +84% in April (Europe's #1 stock). | Bloomberg, Seeking Alpha | LITE, COHR, AAOI, TSEM, AEHR, CRDO | UPDATE (Day 19) | Very High |
| 5 | GOOGL/MSFT earnings after close: GOOGL: $106.9B rev expected (+19% YoY), EPS $2.63 (-6.4% YoY due to AI capex), Cloud growth 50%+ watched. Options price 5.63% move (vs 1.44% typical). MSFT: $81.3B rev, EPS $4.06, Azure 37-38% CC growth guided. OpenAI restructure overhang. Both report after close today. | SA, Kiplinger, Yahoo Finance | GOOGL, MSFT, NVDA, ORCL | NEW | Very High |
| [PARTIALLY VERIFIED -- GOOGL $106.9B rev confirmed (SA, S&P Global, CoinDCX). EPS $2.63 confirmed. Cloud growth ~49.6% (SA) not "50%+". MSFT rev consensus $81.46B (Bloomberg) not $81.3B; EPS consensus $4.04 (Bloomberg) not $4.06. Azure 37-38% CC guide confirmed (MSFT guidance). Minor discrepancies in MSFT figures.] | |||||
| 6 | Rocket Lab $190M DoD hypersonic deal: $190M contract for |
Space.com, Motley Fool, SpaceNews | RKLB | NEW | Very High |
| [PARTIALLY VERIFIED -- $190M confirmed. Contract is for 20 launches (GlobeNewsWire, Rocket Lab IR), not "20+". Q4 revenue $180M confirmed but annual growth was 38% (RKLB IR), not 36%. Q1 guide $185-200M and +57% YoY confirmed. Backlog >$2B confirmed (Yahoo Finance). Neutron targeted Q4 2026 after tank test failure, not "launch permit filed".] | |||||
| 7 | NRC Part 53 effective today: Risk-informed, technology-inclusive advanced reactor licensing framework now live. TerraPower Natrium construction permit approved unanimously. HALEU fuel fast-tracked but proliferation concerns emerging. DOE: first 5-10 reactors "almost certainly" get federal loans. |
Nuclear-news, NRC, ANS | OKLO, LEU, NKLR, SMR | NEW | High |
| [PARTIALLY VERIFIED -- NRC Part 53 effective April 29, 2026 confirmed (NRC, ANS, Morgan Lewis). First new framework since 1989. TerraPower Natrium CP approved March 4, 2026 (TerraPower IR, ANS). NuScale $532M loss was Q3 2025 driven by $495M ENTRA1 payment -- NOT a recent event. Fluor fully exited ~40M shares. DOE loan pipeline confirmed.] | |||||
| 8 | RVMD new 52w high: $144.83 (+10% from yesterday's $131.67), touched $155.70 intraday (new 52w high). Phase 3 daraxonrasib OS doubled in PDAC. ASCO Plenary May 31 confirmed. Evercore PT $200. Sentiment: Asymmetric (+9). | MarketBeat, SA | RVMD | UPDATE (Day 18) | Very High |
| [VERIFIED -- $144.83 close and $155.70 52w high confirmed (Yahoo Finance, MarketBeat). Phase 3 OS 13.2 vs 6.7 months, HR 0.40 confirmed (Revolution Medicines IR, PanCAN, OncLive). ASCO Plenary confirmed (Revolution Medicines IR).] | |||||
| 9 | ONDS best month +16%, Mistral merger complete: $457M pro forma backlog. Mistral THOR drone deal with US Army Small UAS Product Office. Battlefield showcase this week. ONBERG JV with Heidelberg (Germany). Israel $50M Eastern Border Security. FCC Golden Dome brochure. | StockTitan, GlobeNewsWire | ONDS | UPDATE (Day 3) | Medium-High |
| [VERIFIED -- Mistral merger completed Apr 24 for $175M confirmed (Ondas IR, Investing.com). $457M backlog confirmed (StockTitan, StockTwits). World View acquisition Apr 1 confirmed. Israel border security order confirmed.] | |||||
| 10 | Goldman blocks Claude in Hong Kong: Goldman Sachs staff in HK lost Claude access due to strict Anthropic contract interpretation. Other AI tools (Gemini, ChatGPT) still available. Anthropic says Claude was never officially "supported" in HK. Rising US-China AI access tensions. | Bloomberg, Reuters, FT | GOOGL (Gemini gains) | NEW | High |
| [VERIFIED -- Confirmed by Bloomberg, Reuters, FT, Yahoo Finance, Seoul Economic Daily. Goldman contract interpretation, Gemini/ChatGPT still available, all confirmed. "Distillation" concern noted by Bloomberg as context.] |
Prior Signal Tracker
- OpenAI revenue miss -- ONGOING (Day 2): ORCL -7.5% impact fading. NVDA resilient. MSFT earnings today key test. (ORCL, NVDA, MSFT)
- INTC euphoria -- ONGOING (Day 6): $84.52 (2.16x 200MA). HSBC $95. Still 94x P/E. (INTC)
- Trump-Xi summit -- ONGOING (Day 5): May 14-15 Beijing. USTR 301 hearings ongoing. Trump China visit 64% on Kalshi. (AAPL, NVDA, AXTI)
- NSB firing -- ONGOING (Day 4): NIH funding lag continues. (RVMD, NVCR indirect)
- DeepSeek V4 -- ONGOING (Day 6): V4-Pro 1.6T params, MIT license, scores alongside GPT-5.5 and Opus 4.7. (NVDA, NBIS)
- Meta 10% layoffs -- ONGOING (Day 6): Manus acquisition blocked by China. (META, NBIS)
- Samsung D1d DRAM -- ONGOING (Day 6): MU near ATH $504.29. (MU, AMKR)
- RVMD oncology -- UPDATE (Day 18): New 52w high $155.70! ASCO Plenary May 31. (RVMD)
- Tim Cook succession -- ONGOING (Day 9): AAPL $270.71, earnings Apr 30. UBS $287 PT. (AAPL)
- Amazon $25B Anthropic -- ONGOING (Day 9): AMZN $259.70 near ATH. Earnings May 1. (AMZN)
- Pentagon drone mobilization -- UPDATE (Day 21): RKLB $190M HASTE deal. ONDS Mistral showcase. (KTOS, ONDS, RKLB)
- TSLA -- ONGOING (Day 13): Below 200MA (0.94x). Goldman $375 Neutral. (TSLA)
- HIMS peptide -- ONGOING (Day 15): $27.91 (0.74x 200MA). JPM OW $35. Peptide reclassification tailwind. (HIMS)
- NBIS Meta deal -- ONGOING (Day 16): $135.51 (1.39x 200MA). AI21 talks + Aether launch. (NBIS)
- GOOGL earnings -- UPDATE: Reports tonight. Near ATH $349.78. (GOOGL)
- MU HBM structural -- ONGOING (Day 20): $504.29 (1.86x). 3/5 exhaustion. (MU)
- NVCR PANOVA-4 -- ONGOING (Day 16): Earnings tomorrow pre-market. FDA Optune Pax approved. (NVCR)
- RKLB -- UPDATE (Day 15): $190M HASTE deal! Backlog >$2B. $78.59 (1.28x 200MA). (RKLB) [VERIFIED -- Note: Signal 6 labels HASTE "NEW" but this tracker correctly shows Day 15. Contract was March 18. The "NEW" tag on Signal 6 is inconsistent with this Day 15 tracker entry.]
- INFQ -- ONGOING (Day 13): DARPA HARQ + NVIDIA Ising. $12.62 (1.05x). (INFQ)
- BTU oil thesis -- RECOMMEND REMOVAL (Day 33): No fresh catalyst. Below 200MA (0.96x). (BTU)
- SpaceX IPO -- ONGOING (Day 9): Confidential S-1 filed Apr 1. $2T+ target valuation. (RKLB) [VERIFIED -- Confidential S-1 filed Apr 1 confirmed (Bloomberg, Motley Fool, 24/7 Wall St). Initial target $1.75T, boosted to $2T+ the next day (Bloomberg). 21 underwriters led by Morgan Stanley. Roadshow targeting week of June 8.]
- AEHR record order -- ONGOING (Day 15): $82.43 (2.67x). 3/5 exhaustion but monopoly position. (AEHR)
- CATL sodium-ion -- ONGOING (Day 2): 60 GWh order. NOT on investing subs. (AMPX competitive threat)
- OKLO-LEU JV -- ONGOING (Day 4): OKLO $69.09. SI ~17.14M per Finviz. NVIDIA+Los Alamos partnership. (OKLO, LEU) [PARTIALLY VERIFIED -- Finviz shows 17.14M shares short. However, MarketBeat reports 28.6M shares short as of Apr 15 (18.5% increase from Mar 31). Discrepancy likely due to different reporting dates. Sentiment scan claims "24.1M SI at ATH" which is a third different figure. SI data inconsistent across report sections.]
- VRT earnings -- ONGOING: $305.03 (1.61x 200MA). (VRT)
- Gas plant cost inflation -- ONGOING (Day 5): +66%. Nuclear pre-migration. (OKLO)
- Cerebras IPO -- ONGOING: Mid-May under CBRS. (NBIS comp risk)
- DPA grid invocation -- ONGOING (Day 4): $323M FY26. (AMPX, VRT)
- DJI FCC block -- ONGOING (Day 7): Pre-migration. (ONDS, KTOS)
- DOE nuclear fuel recycling -- ONGOING (Day 7): Pre-migration. (OKLO, LEU)
- NFLX $25B buyback -- ONGOING (Day 7): $92.27 (0.88x 200MA). (NFLX)
- Helium crisis -- ONGOING (Day 16): No resolution. (MU, NVDA, AEHR, TSEM)
- X-energy IPO -- ONGOING (Day 4): $34.11 (-5.2% from $35.98). Profit-taking. (XE, OKLO, LEU)
- AI capex debt bubble -- ONGOING (Day 2): $400B hyperscaler debt. CDS widening. MSFT earnings today = key test. (MSFT, GOOGL, AMZN)
- CFS fusion grid filing -- ONGOING (Day 2): First-ever. 400MW Fall Line plant. (OKLO, LEU)
- Lilly $2.3B Ajax -- ONGOING (Day 2): JAK2 inhibitor. (Biotech sector)
- Claude Opus 4.7 GA -- ONGOING (Day 4): Goldman HK Claude block. (GOOGL investor)
- AMKR Q1 beat -- ONGOING (Day 2): $71.36 (-5.6%). Post-earnings dip = entry. Needham $90 PT. (AMKR)
Global News
- FOMC holds 3.50-3.75%: Powell's final meeting. Statement flags "elevated inflation uncertainty." Warsh confirmation at 99% on Kalshi. June cut only 8% probability. (All rate-sensitive)
- UAE quits OPEC effective May 1: Third-largest producer leaves after 60 years. Frees ~1.5M bpd spare capacity post-Hormuz. Blow to Saudi-led cartel cohesion. (BTU, LEU)
- Brent surges to $114.64: +2.7%. Trump "unlikely" to accept Iran's latest proposal. 30-country coalition forming. IEA: largest supply disruption on record. (BTU, OKLO, LEU)
- King Charles addresses Congress: Praised NATO, called US-Europe alliance "more important than ever." State dinner at White House. [VERIFIED -- Joint address to Congress Apr 28 confirmed (CNN, CBS, NBC, NPR, C-SPAN, The Royal Family). First British monarch to address Congress since Queen Elizabeth II in 1991. State dinner confirmed. Speech focused on US-UK alliance and indirectly countered Trump's NATO criticism.]
- Israel strikes Lebanon despite ceasefire: At least 10 killed in southern Lebanon. Ceasefire in name only.
- Florida redistricting emergency session: Governor calls fast-track session that could flip Democratic House seats.
- World Bank warns of cumulative wave: "Higher energy prices, then food prices, then inflation." Poorest countries hit hardest.
NuScale $532M quarterly lossCorrection: NuScale's $532M loss was Q3 2025 (driven by $495M ENTRA1 payment), not a recent event. Fluor has since fully exited its ~40M-share stake. Lawsuits mount (securities fraud class action). Stock -12-20% referenced is from 2025. (SMR) [OUTDATED -- $532M loss was Q3 2025, not a current quarter event. Fluor exit completed via ~$2.43B in open-market sales since Sep 2025. Stock fell 70%+ during 2025 class period. Presenting this as current news is misleading (StocksToTrade, TimothySykes, SimplyWallSt).]
Geopolitical & Macro
Strait of Hormuz / Iran -- Day 16 (UAE LEAVES OPEC)
UAE announced OPEC exit effective May 1, ending 60 years of membership. Trump "unlikely" to accept Iran's latest proposal to reopen Hormuz while deferring nuclear talks. Brent surged to $114.64 (+2.7%), highest since crisis began. Mojtaba Khamenei named new supreme leader but believed seriously wounded. [VERIFIED -- Mojtaba Khamenei succeeded his father after Feb 28 assassination. Injuries confirmed by CNN, Al Jazeera, Times of Israel, RNZ. Hegseth statement on "wounded and likely disfigured" confirmed. IRGC generals reportedly governing in practice (Times of Israel).] 30-country Hormuz safeguard coalition forming. Baker Hughes: strait closed through H1.
Structural shift: UAE exit strips OPEC of third-largest producer and frees spare capacity for post-crisis production surge. Near-term bullish oil (crisis continues), medium-term bearish for OPEC price discipline.
Affected: BTU (+coal substitute), LEU/OKLO (+nuclear urgency), IREN (-energy cost headwind), all rate-sensitive (inflation)
Kalshi: "US-Iran nuclear deal this year?" -- 0% Yes | Assessed: 0%. Iran proposal dead. Agree. Kalshi: "Trump visits China before May 15?" -- 64% Yes | Vol: 202K | Assessed: ~60%. Summit confirmed but format fluid. No edge. Kalshi: "April CPI YoY >3.6%" -- 66% Yes (was 58% yesterday) | Assessed: ~75%. Brent $114 pass-through + Hormuz. BUY Yes at 66c = ~9pp edge (narrower than yesterday). Kalshi: "CPI MoM >0.5% in April?" -- 52% Yes | Assessed: ~60%. Energy pass-through. BUY Yes at 52c = ~8pp edge (below threshold but directional).
FOMC Apr 28-29 -- Powell's Last Meeting (CONCLUDED)
Hold at 3.50-3.75% confirmed. Statement flagged "elevated uncertainty" on inflation from energy shocks. CPI March 3.3% YoY (highest since May 2024). Warsh confirmation 99% on Kalshi. June cut only 8%, June hike 2%. No cuts likely until Hormuz resolves.
Affected: All rate-sensitive growth (HIMS, NFLX, NET, RKLB, ONDS/HOVR/ULBI small-cap cost of capital)
Sulfuric Acid Ban -- T-1 Day (May 1)
China export ban effective tomorrow. Pentagon timelines for rare earth magnet production delayed 18-24 months. "Catch-22": US needs Chinese acid to process domestic rare earths to reduce Chinese dependency. Double squeeze: Hormuz blocks Middle East sulfur (50% seaborne trade), China removes last flexible supply. Spot prices surging in Asia.
Affected: MP (strong positive -- supply squeeze), LEU (uranium leaching cost), AEHR/TSEM/AMKR (semiconductor-grade acid risk)
US-China -- USTR 301 Hearings Continue
May 5-8 hearings target Chinese excess capacity. Trump-Xi summit May 14-15 confirmed (Kalshi 64% Trump visits). AXTI InP export permit risk elevated. Current tariff baseline: 25% most goods, 100% EVs, 50% semiconductors.
Affected: NVDA/AMKR/TSEM/CEVA (semiconductor tariffs), AAPL (assembly), MP (rare earth leverage +), AXTI (export risk)
Interest Area News
- LLM Agents -- Agent2Agent (A2A) v1.0 and MCP now official with SDKs in 7 languages. Google released open-source terminal agent (ReAct loop, MCP, 1M context, Apache 2.0). Anthropic holds 40% of enterprise LLM API spend, OpenAI dropped to 27%. 57% of organizations now have agents in production.
- Claude & AI -- Goldman HK staff lose Claude access (contract interpretation, not tech ban). Anthropic released 9 creative connectors (Blender, Adobe, Autodesk, Ableton, Splice). Claude Design in research preview. Claude Mythos 5 (10T params) announced but not released (ASL-4). DeepSeek V4-Pro released (1.6T, MIT license, scores alongside GPT-5.5/Opus 4.7).
- Open Source -- Densest wave of open source AI in history: Qwen 3.5 (community #1), Gemma 4 (local), GLM-5/GLM-4.7, MiniMax M2.5/M2.7 (agentic), Phi-4-reasoning (14B, strong benchmarks), DeepSeek V4. "Good enough" inference cost dropped 50% since January.
- Cybersecurity -- Microsoft April Patch Tuesday: 164 CVEs, 8 Critical. SharePoint zero-day CVE-2026-32201 actively exploited (CISA KEV). BlueHammer Defender zero-day CVE-2026-33825. Windows TCP/IP RCE CVE-2026-33827 (CVSS 8.1, unauthenticated). MCP server exploitation emerging as attack surface. Action: verify SharePoint patches applied.
- Developer Tools -- Visual Studio 2026 GA ("first intelligent IDE"). RustRover 2026.1 with cargo-nextest. JetBrains unifying distributions. Claude Code undisputed CLI king; OpenAI Codex catching up with background agents. AI copilot graduated from novelty to core development partner.
- Edge Computing -- Luce DFlash running Qwen3.6-27B at 2x throughput on single RTX 3090. Google TurboQuant reduces KV cache overhead at ICLR 2026. Neural networks + symbolic reasoning = 100x energy reduction (ScienceDaily). ASUS UGen300 (17 TOPS, 2.5W).
- Space -- Rocket Lab $190M HASTE deal, Neutron launch permit filed (H2 2026). SpaceX 50th mission of 2026, S-1 filed ($2T+ valuation). Blue Origin New Glenn stage recovery success but payload in wrong orbit. CFS fusion grid filing confirmed (400MW Fall Line, VA).
Early Signals (Expert Subs)
- r/energy [1466 upvotes, 82c]: "Trump's attempt to crush clean energy progress not going to plan" -- Clean energy resilience narrative strengthening. Major mainstream engagement on r/energy. (LEU, OKLO, XE)
- r/energy [165 upvotes, 80c]: "Trump told aides to prepare for lengthy Strait of Hormuz blockade" -- WSJ. Expert framing: extended conflict timeline, $114+ Brent structural. (LEU, BTU)
- r/energy [118 upvotes, 26c]: "Energy experts expect another spike at the pump" -- Experts framing gas spike as structural (Hormuz + refinery), not transient. Contrasts mainstream "temporary" framing.
- r/fusion [5 upvotes]: "US and Europe Lock In Decade-Long Stellarator Fusion Research Deal" -- W7-X collaboration formalized. Stellarator pathway gaining institutional support. (OKLO, LEU)
- r/Biohackers [237 upvotes, 103c]: "GLP1 drugs could regrow cartilage" -- GLP-1 indication expanding beyond obesity into orthopedics. TAM expansion signal. (NVO, HIMS)
- r/Biohackers [34 upvotes, 13c]: "FDA's peptide committee votes on 7 compounds in July. It has never approved a peptide." -- Regulatory headwind for compounders. (HIMS risk factor)
- r/biotech [26 upvotes, 5c]: "Health Canada approves 1st generic version of Ozempic" -- First crack in NVO's GLP-1 moat. (NVO bearish, HIMS mixed)
- r/biotech [7 upvotes]: "AbbVie sinks talons into KRAS with $1.45B Kestrel deal" -- KRAS therapy M&A heating up. Validates precision oncology. (RVMD adjacent)
- r/chipdesign [544 upvotes, 84c]: "The rarity of Chip Design Engineers" -- Talent scarcity as structural constraint on fab expansion. (TSEM, AMKR, CEVA)
- r/chipdesign [12 upvotes, 2c]: "Karpathy's autoresearch loop on RISC-V CPU (+92%)" -- AI-assisted chip design achieving 92% improvement. (NVDA, semiconductor sector)
- r/CredibleDefense [44 upvotes, 94c]: "Active Conflicts Megathread April 28" -- Expert consensus: prolonged Hormuz disruption likely. (KTOS, defense)
- r/LocalLLaMA [453 upvotes, 89c]: "Something from Mistral (Vibe) tomorrow" -- New Mistral model launch imminent. Open-weight competition intensifying.
- r/LocalLLaMA [200 upvotes, 73c]: "Nemotron-3-Nano-Omni-30B-A3B-Reasoning" -- NVIDIA small reasoning model. Inference optimization push. (NVDA)
- r/LocalLLaMA [108 upvotes, 19c]: "Xiami mimo-v2.5 pro MIT license surpasses Opus 4.5 on arena" -- Chinese open-source beating Opus 4.5 on Arena.
- r/QuantumComputing [10 upvotes, 16c]: "Classical simulation wall isn't at 50 qubits -- it's at entanglement depth" -- Reframes quantum advantage thresholds. (INFQ)
- r/robotics [53 upvotes, 17c]: "Boston Dynamics Trailer Unloading at MODEX" -- Logistics automation demo. Warehouse robotics deployment accelerating. (NOVT)
- r/robotics [43 upvotes, 3c]: "MuscleMimic: Unlocking full-body musculoskeletal motor learning at scale" -- Novel humanoid control. Validates long-term humanoid thesis.
Investing Chatter (DD & Mainstream)
- r/wallstreetbets [2396 upvotes, 339c]: "Warren Buffett holds $373.3B in cash" -- Historic cash position generating retail anxiety. Interpreted as mega-bear signal.
- r/wallstreetbets [1797 upvotes, 183c]: "BP profits more than double, beating expectations as Iran war boosts oil prices" -- Oil supermajor earnings validating Hormuz thesis. WSB: "war profiteering." (BTU, LEU)
- r/ValueInvesting [351 upvotes, 96c]: "Anthropic Valuation Hits $1 Trillion on Pre-IPO Trading, Up 733% Since October" -- Contrasts with OpenAI miss. Market bifurcating AI winners vs losers.
- r/investing [227 upvotes, 61c]: "UAE ditching OPEC at beginning of May" -- OPEC fracturing signal. Counterweight to Hormuz premium. (BTU, energy)
- r/investing [226 upvotes, 62c]: "China is mass producing sodium-ion batteries and I think it changes the entire investing thesis" -- CATL sodium-ion reframing lithium demand. (MP indirect risk)
- r/investing [103 upvotes, 21c]: "The Fed chair transition happening now may matter more than today's rate decision" -- Powell-to-Warsh transition getting attention. Warsh perceived as more hawkish.
- r/stocks [87 upvotes, 96c]: "I feel like I should start looking at AMD and MU for the second half of AI" -- Retail discovering MU near ATH. Late signal. (MU -- hype risk)
- r/stocks [48 upvotes, 9c]: "Accenture to roll out Copilot to 743,000 employees" -- MSFT enterprise AI adoption validation ahead of earnings. (MSFT)
- r/pennystocks [6 upvotes, 1c]: "Kopin MicroLED-Based Optical Interconnect for AI" -- KOPN/Fabric.AI MicroLED as SiPh alternative. $15M order. (KOPN vs POET, SiPh cluster)
- r/options [3 upvotes, 15c]: "Today's vol setup feels asymmetric -- Powell's last presser + Warsh + 160 USD/JPY" -- Multi-catalyst convergence flagged.
Ticker-Specific Intel (Tier 3)
- r/RKLB [88 upvotes, 34c]: "Cathie Wood Offloads Rocket Lab Stock Despite 3% Jump, Buys Intellia" -- ARK selling RKLB. Potential distribution signal. (RKLB)
- r/INFQ [50 upvotes, 14c]: "Infleqtion Awarded $1M U.S. Navy Contract for Quantum Accelerated AI Radio" -- Navy quantum-AI contract validates defense use case. (INFQ)
- r/OKLOstock [24 upvotes, 2c]: "Oklo Q1 Earnings Date Set: 5/12" -- Pre-revenue check-in catalyst. (OKLO)
- r/ONDS [40 upvotes, 9c]: "Siemens Mobility $390M NYC digitalization -- ONDS tech may be embedded" -- Supply chain derivative play. (ONDS)
- r/ONDS [11 upvotes, 4c]: "Firestorm $82M Series B raise -- Ondas partnership" -- Partner raising significant capital. (ONDS)
- r/HIMSstock [10 upvotes, 32c]: "Whats going on?" -- Cautious sentiment ahead of FDA peptide committee headwind in July. (HIMS)
Signal Migration
- Hormuz blockade duration: r/CredibleDefense (44 upvotes) + r/energy (165 upvotes) --> r/wallstreetbets (BP profits 1797 upvotes). Gap: Experts see structural multi-month disruption; retail treating as a trade. (LEU, BTU)
- Sodium-ion battery disruption: r/investing (226 upvotes) but NOT r/batteries or r/electricvehicles. Inverted: investing community processing before domain experts. May indicate narrative ahead of technical validation. (MP risk)
- GLP-1 TAM expansion (cartilage): r/Biohackers (237 upvotes) only. NOT on investing subs. Pre-migration: If data holds, materially expands addressable market. (NVO, HIMS)
- FDA peptide committee (July): r/Biohackers (34 upvotes) only. NOT on investing radar. "Never approved a peptide" = bearish compounders. Pre-migration with catalyst date. (HIMS risk)
- MicroLED optical interconnects (KOPN): r/pennystocks (6 upvotes). NOT in r/photonics or r/chipdesign. Alternative to laser-based SiPh. (KOPN vs SiPh cluster)
- Sulfuric acid T-1: STILL not discussed on Reddit despite implementation tomorrow. This silence means market impact on May 1 could be outsized. (MP)
- Anthropic $1T valuation: r/ValueInvesting (351 upvotes) vs OpenAI revenue miss. Market bifurcating AI winners (Anthropic 40% enterprise API share) vs losers (OpenAI 27%). NOT yet framed as "sell OpenAI-dependent, buy Anthropic-dependent." (GOOGL, MSFT) [VERIFIED -- Anthropic $1T pre-IPO valuation confirmed on Jupiter Prestocks and Forge Global (Yahoo Finance, Seeking Alpha, TipRanks). 733% increase since Oct 2025 confirmed. Run-rate revenue $14B confirmed. However, Hiive prices Anthropic shares at $851B, not $1T -- valuation varies by secondary market platform.]
Unverified -- treat as signal, not fact.
Narrative Divergence
| Story | Mainstream | Reality | Gap | Tickers | Play |
|---|---|---|---|---|---|
| Hormuz duration | CNBC: "negotiations ongoing," understating Brent by ~$3-5 | WSJ/r/CredibleDefense: Trump preparing for "lengthy blockade." Dual blockade structure makes resolution structurally difficult. Brent $114.64, not ~$110. | Significant -- mainstream understating duration and price | LEU, BTU, OKLO | Long energy duration plays |
| UAE OPEC exit | "Blow to OPEC, oil price positive" (CNN, WaPo) | Near-term bullish (crisis) but medium-term bearish for OPEC price discipline -- UAE spare capacity floods market post-Hormuz | Significant -- missing medium-term supply implication | BTU, LEU, OKLO | Position for post-Hormuz reversal |
| AI capex / OpenAI miss | "One-quarter miss, NVDA resilient" | r/LocalLLaMA: Open-source (Mistral Vibe, Xiami mimo, DeepSeek V4) eroding frontier moat. Revenue miss is structural. Anthropic $1T vs OpenAI struggling. | Significant -- structural competitive pressure, not cyclical | MSFT, ORCL, GOOGL | Differentiate inference/edge vs training spend |
| Sulfuric acid ban (May 1) | Limited mainstream coverage | S&P Global: "Catch-22" for US rare earth independence. Pentagon delays 18-24 months. Chile/DRC disruption. Reddit silence = surprise potential. | Significant -- barely covered, T-1 | MP, LEU | Supply chain squeeze imminent |
| SiPh post-POET | "Sector risk exposed" (retail) | POET = $1M revenue + CFO governance failure. SiPh fundamentals intact. KOPN MicroLED alternative emerging (r/pennystocks). | Moderate -- sympathy pullbacks = entry | CRDO, COHR, TSEM | Buy CRDO/TSEM at POET-discounted levels |
Key divergences: (1) Hormuz blockade duration systematically understated -- experts indicate multi-month while CNBC implies near-term resolution. (2) UAE OPEC exit is medium-term bearish for oil discipline, not just crisis-bullish. (3) Sulfuric acid ban tomorrow has near-zero Reddit/mainstream coverage -- surprise potential is high.
Claude & AI
- Goldman HK blocks Claude access: Contract interpretation blocks all Anthropic products for Hong Kong staff. Gemini and ChatGPT remain available. Rising US-China AI access tensions. Anthropic says Claude was never "supported" in HK.
- 9 creative connectors launched: Blender, Adobe, Autodesk, Ableton, Splice integration. Claude positioned as creative collaborator. Claude Design in research preview.
- Claude Mythos 5 announced (not released): 10T parameters, cybersecurity-focused. Held back under ASL-4 safety protocol. Not for API/public use. [PARTIALLY VERIFIED -- 10T parameters confirmed (Medium, DEV Community, BuildFastWithAI). ASL-4 threshold triggered confirmed. However, "announced" is misleading -- details leaked via accidental CMS exposure in late March, not a formal announcement. A limited preview was shared with 11 organizations for cybersecurity on Apr 7.]
- DeepSeek V4 challenges: V4-Pro (1.6T, 49B active) scores alongside GPT-5.5 and Opus 4.7. MIT license. 1M token context. Costs 1/20th of Opus. Open source closing the gap. [VERIFIED -- 1.6T params, 49B active, MIT license, 1M context all confirmed (HuggingFace, Simon Willison, BuildFastWithAI). Released Apr 24. Also includes V4-Flash (284B/13B active). Cost comparison and benchmark claims broadly confirmed.]
- Anthropic 40% enterprise API share: OpenAI dropped to 27%. Pricing power confirmed by 9x Copilot increase + Pro lockdown. [VERIFIED -- Anthropic 40% enterprise LLM spend, OpenAI 27%, confirmed by multiple sources (SaaStr, Medium, X/rohanpaul, LinkedIn). 65% of new AI purchasers in March chose Anthropic. Run-rate revenue $14B confirmed.]
- Novo Nordisk x OpenAI: Strategic partnership for drug discovery to manufacturing. Full deployment by end of 2026. Pilot programs across R&D, manufacturing, commercial.
- Action: Anthropic's geopolitical access restrictions (Goldman HK) signal fragmentation in AI tool availability. Enterprise API share dominance confirms moat.
Frontier Tech
Silicon Photonics -- Scaling (Day 19)
Post-POET stabilization. POET recovered to $8.03 (+1%). SiPh cluster pulled back in sympathy: LITE $791 (-7.9%), COHR $304 (-5.5%), TSEM $194 (-5.1%), AAOI $137 (-5.8%), CRDO $166 (-8.1%). Fundamentals unchanged: $2.6B to $34.3B market by 2035, EML laser 40-60% shortfall, OCI Alliance intact, Soitec +84% April Correction: Soitec +298% over 3 months; April gains alone were larger than 84% (Europe's best stock), Coherent 400Gbps NVDA supply deal expanded. POET sympathy pullbacks = best entry since SiPh cluster formed. CRDO at 1.22x 200MA is best value in cluster.
[PARTIALLY VERIFIED -- POET -47% crash on Marvell order cancellation due to CFO confidentiality breach confirmed (Motley Fool, Benzinga, Seeking Alpha). CRDO DustPhotonics $750M confirmed (BusinessWire, Credo IR). Soitec figure understated: stock surged 22.9% on Apr 17 and 31.4% on Apr 20; +298% over 3 months per Ideal-Investisseur. The "+84% April" appears too conservative.]
Nuclear Energy -- Early Commercial (NRC Part 53 Live)
NRC Part 53 effective today -- risk-informed, technology-inclusive advanced reactor licensing framework. TerraPower Natrium construction permit unanimously approved (HALEU fuel, proliferation debate). NuScale $532M quarterly loss Correction: NuScale Q3 2025 loss (stale data), stock decline was 2025 event, Fluor has fully exited. XE at $34.11 (-5.2%), profit-taking. OKLO $69.09 (0.80x 200MA), NVIDIA+Los Alamos partnership. CFS fusion grid filing confirmed. DOE: "first 5-10 reactors almost certainly get federal loans." NKLR at $6.34 -- only ticker scoring 14/21 on TA.
[VERIFIED -- Part 53 effective Apr 29 confirmed (NRC). TerraPower CP approved Mar 4 confirmed (TerraPower IR). CFS PJM grid filing Apr 28 confirmed (PRNewswire, Axios). CFS plant is 400MW "Fall Line" in Chesterfield County, VA confirmed. NKLR is Terra Innovatum Global confirmed (GlobeNewsWire). NuScale loss is OUTDATED -- see correction above.]
Cancer Therapeutics -- Clinical Breakthrough
RVMD hit new 52w high $155.70 (intraday). Phase 3 OS doubled in PDAC (13.2 vs 6.7mo, HR 0.40). ASCO Plenary May 31. Evercore PT $200. NVCR earnings tomorrow pre-market -- FDA Optune Pax approved, PANOVA-4 positive, Japan reimbursement. Lilly retatrutide producing 23.7% weight loss (obesity mega-trend). ADC peptide linkers achieving >85% tumor-specific delivery.
Drones & Autonomous -- Scaling
RKLB wins $190M HASTE hypersonic test deal (20+ launches). ONDS best month +16% on Mistral merger ($457M backlog), THOR drone deal with US Army, battlefield showcase this week. JEDI ETF at $100M AUM. AVAV at $192 (0.71x 200MA). Drone market $73B to $164B by 2030. SpaceX 50th mission of 2026.
Battery Technology -- Early Commercial
CATL 60 GWh sodium-ion (world's largest) still pre-migration. China iron-air 99.4% efficiency. AMPX at $19.69 (1.68x) -- new EV customer + EBITDA positive guide but 3/5 exhaustion. Lilly retatrutide (GLP-1 demand) driving EV weight optimization demand. CATL structural competitive threat to lithium-ion economics.
Quantum Computing -- Research
NVIDIA Ising rally fully reversed (IonQ +72%, D-Wave +56% now unwound). DOE Grand Challenge targeting fault-tolerant QC by 2028 is durable catalyst. INFQ at $12.62 (1.05x 200MA), DARPA HARQ + NVIDIA Ising dual validation. D-Wave $884.5M record cash. No near-term binary events.
Robotics / Edge AI -- Early Commercial
Novo x OpenAI partnership signals pharma-robotics convergence. Unitree G1 humanoid advancing. NOVT at $128.98 (1.06x 200MA) -- NVIDIA Halos membership + earnings May 11. CEVA NeuPro-Nano won AI award at Embedded World 2026. Surgical robotics market $14.45B in 2026. Global robotics market $124B.
Peptides & Longevity -- Regulatory Inflection
Google search interest in "peptides" +80% YoY. Market $164B in 2026, growing to $295B by 2033. Lilly retatrutide Phase 3: 23.7% weight loss, FDA filing Q4 2026/Q1 2027. FDA reclassifying peptides out of Category 2. HIMS beneficiary -- Kennedy peptide announcement drove shares. Market $164B and growing. (HIMS)
Kalshi Opportunities
| Event | Market | Kalshi | Assessed | Edge | Bet |
|---|---|---|---|---|---|
| April CPI >3.6% | KXCPIYOY-26APR-T3.6 | 66% Yes | ~75% | +9pp | BUY Yes -- Brent $114 + Hormuz (narrower edge than yesterday) |
| Iran nuclear deal 2026 | KXUSAIRANAGREEMENT-27-26MAY | 0% Yes | 0% | 0pp | Agree -- no framework |
| Warsh confirmed | KXFEDCHAIRCONFIRM-KWAR | 99% Yes | 99% | 0pp | Agree -- locked in |
| Fed June cut | KXFEDDECISION-26JUN-C25 | 8% Yes | ~5% | -3pp | No edge -- directionally agree |
| WTI >$103 today | KXWTI-26APR29 | 66% Yes | ~70% | +4pp | No edge -- too tight |
| Trump visits China pre-5/15 | KXTRUMPCHINA-26-MAY15 | 64% Yes | ~60% | -4pp | No edge |
Supply Chain Derivatives
| Primary Signal | Derivative Sector | Stage | Tickers | Why |
|---|---|---|---|---|
| SiPh supercycle | Edge AI inference IP | Unnoticed | CEVA ($24.84, 1.08x) | Drone+robot autonomy inference. Royalty model. Not tagged to SiPh wave. NeuPro-Nano award. |
| SiPh supercycle | Optical DSP/transceivers | Early | CRDO ($165.92, 1.22x) | Lowest 200MA ratio in SiPh cluster. $750M DustPhotonics vertical integration. Post-POET discount. |
| Nuclear SMR buildout | Specialty materials | Unnoticed | ATI ($151.70, 1.37x) | Reactor vessels need specialty steel/zirconium. Nuclear primaries surged, ATI following. |
| [VERIFIED -- ATI is a confirmed supplier of zirconium alloys for nuclear applications. ATI was the first industrialized manufacturer of zirconium. Products include fuel cladding materials and reactor components (ATI Materials). Supply chain relationship is real.] | ||||
| Nuclear SMR buildout | HALEU fuel enrichment | Early | LEU ($205.59, 0.82x) | Only US HALEU enricher. Below 200MA. $900M Piketon + CFS + acid ban. |
| CFS fusion grid filing | HTS magnet materials | Unnoticed | ATI | Specialty alloys for fusion magnets. CFS private; ATI is public derivative. |
| [PARTIALLY VERIFIED -- CFS grid filing confirmed (PRNewswire, Axios). ATI makes specialty alloys but no confirmed public supply agreement with CFS for fusion magnets specifically. HTS magnet materials for fusion are typically REBCO superconducting tape (not ATI's core product). Supply chain link is plausible but not confirmed.] | ||||
| Drone proliferation | Specialty defense batteries | Unnoticed | ULBI ($7.03, 1.06x) | NDAA-compliant batteries. $119M micro-cap. Not yet connected to ONDS surge. |
| Drone proliferation | NDAA-compliant batteries | Early | AMPX ($19.69, 1.68x) | $35M order, sole-source defense positioning. Near profitability. |
| Sulfuric acid ban | Domestic RE processing | Early | MP ($61.70, 0.98x) | Only US integrated mine+processor. Ban effective tomorrow. |
Momentum Leaders (Structural Re-Rates)
| Theme | Leader | Price / 200MA | Fresh Catalysts (last 7d) | Score | Action |
|---|---|---|---|---|---|
| Oncology/PDAC | RVMD | $144.83 / 1.94x | New 52w high, Evercore $200, ASCO Plenary May 31, $2.23B raise | 9 | Add on dips $130-140 |
| AI Memory | MU | $504.29 / 1.86x | HBM4 mass prod, Arete $852 PT, MATCH Act | 9 | Add on dips $470-500 (3/5 exhaustion) |
| Adv Packaging | AMKR | $71.36 / 1.84x | Record Q1 +27%, Needham $90, $300M buyback, CPU ramp H2 | 9 | Entry -- post-earnings dip |
| SiPh Optics | COHR | $303.97 / 1.74x | NVDA $2B, TD Cowen Buy/$330, earnings May 6, POET pullback entry | 8 | Add on dips $290-305 |
| SiPh Foundry | TSEM | $193.55 / 1.81x | 400Gbps SiPh demo, Axiro SiGe radar, POET sympathy = entry | 8 | Add on dips -- artificial discount |
| SiPh Optics | LITE | $791.37 / 2.16x | JPM $950, Northland $1000, NVDA $2B, backlog 2027 | 8 | Watch -- add on 10%+ pullback |
| Drone/Defense | ONDS | $10.48 / 1.30x | Mistral merger, $457M backlog, THOR Army deal, battlefield showcase | 8 | Add on dips -- highest alpha conviction |
| SiPh SerDes | CRDO | $165.92 / 1.22x | $750M DustPhotonics, POET pullback = widened entry | 7 | Entry -- best alpha in SiPh |
| SiPh Burn-In | AEHR | $82.43 / 2.67x | Record $41M, SiPh customer win -- 3/5 exhaustion | 5 | Trail Stop |
| Battery | AMPX | $19.69 / 1.68x | $35M order, DPA grid, near profitability -- CATL comp | 6 | Watch -- exhaustion 3/5 |
| Intel Recovery | INTC | $84.52 / 2.16x | HSBC $95 -- 94x P/E, Diamond Rapids delayed | 5 | Dangerous to chase |
Best Setups
CRDO -- Credo Technology ($165.92, $30.6B) -- BEST ALPHA IN SIPH CLUSTER (IMPROVED)
Vertically integrated 400G-3.2T SiPh via $750M DustPhotonics acquisition. Lowest 200MA ratio (1.22x) in SiPh cluster vs average >1.8x. POET crash created widened sympathy pullback -- now 22.4% below 52w high $213.80 (was 15.6% yesterday). Sentiment: Accelerating (+7).
- Why now: Best risk/reward in SiPh cluster. POET crash irrelevant to CRDO thesis. Entry window widened.
- Trade: Entry $160-170 / Stop $138 / Target 1 $215 / Target 2 $260 -- 2.8:1 R/R
- Horizon: 3-6 months
- Invalidation: DustPhotonics integration delays, SiPh demand slowdown
- Confidence: Medium-High
RVMD -- Revolution Medicines ($144.83, $30.8B) -- NEW 52W HIGH + ASCO STACKING
Phase 3 OS doubled in PDAC (13.2 vs 6.7mo, HR 0.40). New 52w high $155.70 today. ASCO Plenary May 31. Evercore PT $200. NDA filing H2 2026. Sentiment: Asymmetric (+9). $2.23B capital raise completed.
- Why now: Momentum + approaching catalyst. First-line expansion not priced. Multiple PTs $140-200.
- Trade: Entry $135-145 / Stop $120 / Target 1 $190 / Target 2 $220 -- 2.5:1 R/R
- Horizon: 6-12 months
- Invalidation: NDA rejection, competitive KRAS data
- Confidence: High
AMKR -- Amkor Technology ($71.36, $17.7B) -- POST-EARNINGS DIP = ENTRY
Record Q1 revenue $1.685B (+27% YoY), EPS +43.5% beat. Q2 guided above. $300M buyback. Needham PT $90 (+26% upside). Stock -5.6% post-earnings on margin compression -- classic sell-the-news. CPU ramp H2 2026. [VERIFIED -- Record Q1 $1.685B (+27% YoY) confirmed (Amkor IR, Motley Fool, Investing.com). EPS $0.33 vs $0.22 est confirmed. Q2 guide $1.75-1.85B confirmed. Buyback confirmed. Gross margin 14.2% vs 11.9% YoY confirmed.]
- Why now: Record beat dismissed on margins. AI packaging demand tripling. $90 PT consensus building.
- Trade: Entry $68-73 / Stop $60 / Target 1 $85 / Target 2 $100 -- 2.3:1 R/R
- Horizon: 3-6 months
- Invalidation: CoWoS capacity overshoot, margin deterioration continues
- Confidence: High
LEU -- Centrus Energy ($205.59, $4.0B) -- ASYMMETRIC BELOW 200MA (TRIPLE CATALYST)
Only US HALEU enricher. Below 200MA (0.82x) -- rare asymmetric entry in secular bull theme. Acid ban tomorrow constrains uranium leaching globally. NRC Part 53 effective today. CFS fusion grid validates long-term demand. $900M Piketon. 23.5% SI. B. Riley $295 PT (43% upside).
- Why now: Below 200MA in nuclear bull. Triple catalyst stacking (acid ban, Part 53, CFS). SI squeeze.
- Trade: Entry $200-210 / Stop $180 / Target 1 $280 / Target 2 $350 -- 3.0:1 R/R
- Horizon: 6-12 months
- Invalidation: Piketon delays, HALEU competition
- Confidence: High
MP -- MP Materials ($61.70, $11.0B) -- HARD CATALYST TOMORROW
Only integrated US rare earth mine. Near 200MA (0.98x). Sulfuric acid ban effective tomorrow. Pentagon magnet timelines delayed 18-24 months without domestic acid. Wedbush $90 PT (+46%). Apple $500M + DoD $110/kg floor. NdPr surging.
- Why now: Binary catalyst in <24 hours. Near 200MA. Domestic rare earth monopoly.
- Trade: Entry $59-63 / Stop $52 / Target 1 $80 / Target 2 $100 -- 2.5:1 R/R
- Horizon: 3-6 months
- Invalidation: China relaxes controls, rare earth prices collapse
- Confidence: Medium-High
New Tickers
| Ticker | Company | Cap | Why Now | Risk |
|---|---|---|---|---|
| BWX | BWX Technologies | N/A | Nuclear I&C derivative of SMR buildout. NRC Part 53 effective today. DOE federal loan pipeline. | Pre-revenue SMR, valuation uncertainty. |
No additions to rotating watchlist today -- post-POET sympathy pullbacks in SiPh cluster and acid ban T-1 warrant monitoring existing positions rather than adding new tickers.
Scorecard
Sorted by composite score (descending). Weights: Technical 3, Sentiment 3, Signal 2, Alpha/Catalyst 2. All prices from fetch-prices.py.
| Score | Ticker | Price | Days | Signal | Sentiment | TA | Action |
|---|---|---|---|---|---|---|---|
| 9.5 | RVMD (momentum) | $144.83 | 18 | New 52w high + ASCO Plenary + NDA H2 | Asymmetric (+9) | 1.94x 200MA | Add on dips $130-140 |
| 9.0 | AMKR (momentum) | $71.36 | 14 | Record Q1 +27% beat, Needham $90, $300M buyback | Accelerating (+8) | 1.84x 200MA | Entry -- post-earnings dip |
| 9.0 | COHR (momentum) | $303.97 | 19 | NVDA $2B + TD Cowen $330 + POET pullback entry | Accelerating (+7) | 1.74x 200MA | Add on dips $290-305 |
| 9.0 | MU (momentum) | $504.29 | 20 | HBM4 mass prod + Arete $852 + MATCH Act | Accelerating (+9) | 1.86x 200MA | Add on dips (3/5 exhaustion) |
| 9.0 | CRDO | $165.92 | 15 | $750M DustPhotonics + lowest SiPh + POET discount | Accelerating (+7) | 1.22x 200MA | Entry -- best alpha in SiPh |
| 9.0 | LEU (catalyst) | $205.59 | 25 | $900M Piketon + Part 53 + acid T-1 + CFS + 23.5% SI | Accelerating (+7) | 0.82x 200MA | Entry -- asymmetric |
| 8.5 | ONDS (catalyst) | $10.48 | 20 | Mistral merger + $457M backlog + Army THOR | Accelerating (+8) | 1.30x 200MA | Add on dips -- conviction |
| 8.5 | TSEM (momentum) | $193.55 | 19 | 400Gbps SiPh + Axiro radar + POET sympathy entry | Inflection (+5) | 1.81x 200MA | Entry -- POET artificial discount |
| 8.5 | MP (catalyst) | $61.70 | 14 | Acid ban T-1 + Wedbush $90 + near 200MA | Asymmetric (+8) | 0.98x 200MA | Entry -- hard catalyst tomorrow |
| 8.5 | RKLB (catalyst) | $78.59 | -- | $190M HASTE + backlog >$2B + Neutron permit filed | Accelerating (+5) | 1.28x 200MA | Add on dips |
| 8.0 | HIMS (catalyst) | $27.91 | 15 | Novo partnership + JPM $35 + peptide reclassification | Asymmetric (+9) | 0.74x 200MA | Watch -- May 11 earnings |
| 8.0 | LITE (momentum) | $791.37 | 19 | JPM $950 + Northland $1000 + NVDA $2B | Accelerating (+7) | 2.16x 200MA | Watch -- POET dip = entry |
| 8.0 | NBIS (momentum) | $135.51 | 16 | AI21 talks + Goldman $205 + Aether | Accelerating (+6) | 1.39x 200MA | Hold -- CBRS comp risk |
| 8.0 | INFQ (catalyst) | $12.62 | 13 | DARPA HARQ + NVIDIA Ising + DOE Grand Challenge | Stabilizing (+5) | 1.05x 200MA | Entry -- speculative |
| 8.0 | NVCR (catalyst) | $12.12 | 19 | FDA Optune Pax + PANOVA-4 -- earnings tomorrow | Accelerating (+5) | 0.96x 200MA | Watch -- binary Apr 30 |
| 8.0 | MRVL (momentum) | $153.23 | -- | SiPh Day 19 + 18A + near ATH | Accelerating (+7) | 1.76x 200MA | Add on dips |
| 7.5 | KTOS (catalyst) | $61.66 | 20 | $447M + JEDI $100M + below 200MA | Noise | 0.76x 200MA | Entry -- contrarian |
| 7.5 | NVDA | $213.17 | -- | Near ATH -- OpenAI miss shrugged off | Accelerating (+8) | 1.16x 200MA | Hold |
| 7.5 | OKLO | $69.09 | -- | NVIDIA+LoAlamos + DOE loans + Part 53 | Asymmetric (+7) | 0.80x 200MA | Entry -- SI squeeze potential |
| 7.5 | AMPX (CAUTION) | $19.69 | -- | $35M order + DPA -- CATL comp + exhaustion | Accelerating (+7) | 1.68x 200MA | Watch -- 3/5 exhaustion |
| 7.5 | INTC (CAUTION) | $84.52 | 6 | 2.16x + HSBC $95 -- 94x P/E | Accelerating (+9) | 2.16x 200MA | Dangerous to chase |
| 7.5 | VIAV (catalyst) | $43.17 | 19 | Q3 earnings today + SiPh + 38% growth expected | Accelerating (+5) | 2.13x 200MA | Watch into earnings |
| 7.5 | VRT (momentum) | $305.03 | -- | Near ATH + cooling demand | Accelerating (+5) | 1.61x 200MA | Watch |
| 7.5 | KEYS (momentum) | $332.30 | -- | Near ATH $352.78 + SiPh test demand | Accelerating (+5) | 1.56x 200MA | Watch |
| 7.5 | FN (momentum) | $637.74 | -- | Near ATH $734.79 | Accelerating (+7) | 1.42x 200MA | Watch |
| 7.0 | GOOGL | $349.78 | -- | $40B Anthropic + earnings tonight + near ATH | Accelerating (+7) | 1.26x 200MA | Watch earnings tonight |
| 7.0 | AMZN | $259.70 | -- | Near ATH + $25B Anthropic + earnings May 1 | Accelerating (+8) | 1.15x 200MA | Hold |
| 7.0 | AAPL (catalyst) | $270.71 | 9 | UBS $287 + succession + earnings Apr 30 | Accelerating (+6) | 1.06x 200MA | Watch earnings Apr 30 |
| 7.0 | NET | $208.50 | -- | Post-quantum + AI infra | Accelerating (+4) | 1.03x 200MA | Hold |
| 7.0 | CEVA (derivative) | $24.84 | 19 | Edge AI + NeuPro-Nano award + drone/humanoid | Quiet | 1.08x 200MA | Watch -- Unnoticed |
| 7.0 | NKLR (technical) | $6.34 | -- | 14/21 TA score + NRC Part 53 + near 52w low | Quiet | 1.04x 200MA | Entry -- highest TA score |
| 6.5 | NOVT | $128.98 | 19 | NVIDIA Halos + earnings May 11 | Accelerating (+6) | 1.06x 200MA | Watch |
| 6.5 | IREN | $44.44 | -- | MSCI inclusion + B300 + MSFT deal -- Brent $114 | Accelerating (+7) | 1.07x 200MA | Hold -- energy cost risk |
| 6.0 | NFLX | $92.27 | 7 | $25B buyback + below 200MA | Noise | 0.88x 200MA | Watch $90 support |
| 5.5 | TSLA | $376.02 | 13 | Below 200MA -- Goldman $375 Neutral | Stabilizing (+3) | 0.94x 200MA | Watch |
| 5.5 | MSFT | $429.25 | -- | Below 200MA + earnings tonight + CDS +46% | Stabilizing (+5) | 0.91x 200MA | Watch -- earnings key |
| 5.5 | NVO | $41.17 | -- | Near 52w low -- OpenAI partnership + earnings May 6 | Stabilizing (+2) | 0.82x 200MA | Watch |
| 5.5 | AXTI (CHALLENGED) | $68.71 | 14 | Demand -- dilution + export risk + earnings Apr 30 | Exhaustion (+6) | 3.38x 200MA | Watch -- 4/5 exhaustion |
| 5.0 | AAOI (CAUTION) | $137.26 | 17 | US sovereignty -- 4/5 exhaustion, 51% analyst downside | Exhaustion (+5) | 2.78x 200MA | Trail stop |
| 5.0 | HOVR | $2.11 | -- | Going concern, pre-revenue | Quiet | 1.04x 200MA | Avoid |
| 4.5 | AEHR (CAUTION) | $82.43 | 14 | Record order + monopoly -- 3/5 exhaustion | Accelerating (+8) | 2.67x 200MA | Trail stop |
| 4.5 | ULBI (derivative) | $7.03 | -- | Drone battery + defense -- illiquid $117M | Quiet | 1.06x 200MA | Watch -- Unnoticed |
| 4.5 | BTU | $26.90 | 33d | No fresh catalyst | Accelerating (+5) | 0.96x 200MA | RECOMMEND REMOVAL |
| 4.0 | ORCL | $165.96 | -- | -7.5% on OpenAI miss. 0.78x 200MA. Thin data. | Stabilizing (+1) | 0.78x 200MA | Watch |
Convergence: Brent $114.64 as UAE exits OPEC -- triple squeeze (Hormuz + acid ban tomorrow + OPEC fracture). FOMC holds, flags inflation. RVMD new 52w high. RKLB $190M HASTE deal. NRC Part 53 live. SiPh Day 19 sympathy pullbacks = entry window. CRDO best alpha at 1.22x. LEU triple catalyst below 200MA. AMKR post-earnings dip. MP hard catalyst tomorrow. ONDS best month on Mistral.
Calendar: GOOGL/MSFT/VIAV tonight, AAPL/AXTI/NVCR/NOVT Apr 30, sulfuric acid ban + AMZN May 1, NVO/COHR/KTOS May 6, AAOI/AMPX/RKLB/NET May 7, HIMS/CEVA May 11, NOVT May 12, TSEM May 13, Trump-Xi summit May 14-15, RVMD ASCO May 31.
Rotating Watchlist Changes
- Added: None
- Removed: None (BTU at 33d -- RECOMMEND REMOVAL pending user review)
- Under review: BTU (33d, RECOMMEND REMOVAL), AAOI (4/5 exhaustion, 51% analyst downside), AXTI (4/5 exhaustion + dilution + export risk + earnings Apr 30), AEHR (3/5 exhaustion, 2.67x)
- Thesis updates: LEU -- Part 53 live + acid T-1 + CFS (renew, Day 25). ONDS -- Mistral merger + $457M backlog + THOR Army deal (renew, Day 20). AMKR -- post-earnings dip = entry, Needham $90 (renew, Day 14). RVMD -- new 52w high, Evercore $200 (renew, Day 17). COHR -- POET sympathy = entry, TD Cowen $330 (renew, Day 17). CRDO -- POET discount widens entry to 22.4% below 52w high (renew, Day 15). MP -- acid ban T-1, near 200MA (renew, Day 14).
Staleness Review
| Ticker | Added | Age | Status |
|---|---|---|---|
| BTU | 2026-03-28 | 33d | RECOMMEND REMOVAL: No fresh catalyst. Below 200MA. Noise. |
| LEU | 2026-04-05 | 25d | REVIEW NEEDED: Part 53 + acid T-1 + CFS + Piketon. Below 200MA. Renew. |
| MU | 2026-04-10 | 20d | REVIEW NEEDED: HBM4 + Arete $852. 3/5 exhaustion. Renew. |
| KTOS | 2026-04-10 | 20d | REVIEW NEEDED: $447M + JEDI + below 200MA. No fresh catalyst. |
| NVCR | 2026-04-11 | 19d | REVIEW NEEDED: Earnings tomorrow. FDA Optune Pax approved. |
| NOVT | 2026-04-11 | 19d | REVIEW NEEDED: NVIDIA Halos + earnings May 11. |
| CEVA | 2026-04-11 | 19d | REVIEW NEEDED: NeuPro-Nano award. 1.08x. Renew. |
| LITE | 2026-04-13 | 17d | REVIEW NEEDED: 2.16x. JPM $950, Northland $1000. POET sympathy dip. |
| COHR | 2026-04-13 | 17d | REVIEW NEEDED: TD Cowen $330. POET pullback = entry. Renew. |
| AAOI | 2026-04-13 | 17d | REVIEW NEEDED: 4/5 exhaustion. 51% analyst downside. Earnings May 7. |
| RVMD | 2026-04-13 | 17d | REVIEW NEEDED: New 52w high. Evercore $200. Renew. |
| TSEM | 2026-04-13 | 17d | REVIEW NEEDED: Axiro radar + POET sympathy = entry. Renew. |
| CRDO | 2026-04-15 | 15d | REVIEW NEEDED: POET discount widened entry. Best SiPh alpha. Renew. |
| AMKR | 2026-04-16 | 14d | Post-earnings dip = entry. Needham $90. Renew. |
| MP | 2026-04-16 | 14d | Acid ban T-1. Hard catalyst tomorrow. Renew. |
| AEHR | 2026-04-16 | 14d | CAUTION: 2.67x. 3/5 exhaustion. |
| AXTI | 2026-04-16 | 14d | CHALLENGED: 3.38x + 4/5 exhaustion + CEO selling + earnings tomorrow. |
Rotating Sector Changes
- Added: None
- Removed: None
- Under review: Counter-drone/C-UAS (20d) -- RKLB $190M + ONDS stacking. Renew. Helium supply chain (20d) -- no resolution, dormant. Silicon photonics (17d) -- Day 19, POET sympathy but fundamentals intact. Renew. Rare earth onshoring (14d) -- acid ban T-1. Renew. InP substrate/EML (14d) -- 70% supply gap confirmed. Oncology (17d) -- RVMD 52w high + NVCR earnings. Renew.
Data Quality Notes
- Reddit: intel-reddit completed. 27/28 Tier 1 subs fetched (r/steroids auth-gated; r/DrugNerds, r/graphene, r/nanotechnology, r/photonics, r/quantum returned 0 posts). 12/13 Tier 2 fetched. 7 ticker subs found (RKLB, INFQ, OKLOstock, ONDS, HIMSstock, HIMS, NVDA_Stock). Key: BP profits (1797 WSB), Buffett $373.3B cash (2396 WSB), Anthropic $1T (351 r/ValueInvesting), GLP-1 cartilage (237 r/Biohackers), chipdesign scarcity (544 r/chipdesign).
- Geopolitical / Kalshi: intel-geopolitical agent returned thin. Geopolitical sections run directly in main context with comprehensive WebSearch coverage. Kalshi data fetched via script (2,043 markets from 20,322 open). Key: CPI >3.6% at 66% (edge ~9pp), Iran deal 0%, Warsh 99%, Fed June cut 8%.
- Technical: intel-technical completed. NKLR 14/21 (highest). AMKR 9/21, RVMD 9/21. 3 Momentum Leaders confirmed (MU, AMKR, RVMD).
- Sentiment: intel-sentiment completed. 29 Catalyst / 4 Noise / 4 Quiet. Key: RVMD Asymmetric (+9), HIMS Asymmetric (+9), MP Asymmetric (+8). Exhaustion: AAOI (4/5), AXTI (4/5), MU (3/5).
- Alpha: intel-alpha completed, companion saved. ONDS 8/10 (highest conviction), AEHR 7/10, AMPX 7/10, NVCR 7/10. 11 Momentum Leaders (1 exhausted, 1 watch, 9 actionable). Bottlenecks: InP substrate 70% gap, sulfuric acid.
- Section 5.5 Firehose: All 13 themes searched. SiPh POET sympathy pullbacks = entry window. NRC Part 53 and RKLB HASTE are new signals. Lilly retatrutide weight loss data in peptides. No themes missed.
- Price data: Main + rotating from Phase 0 (37 tickers). INTC, MRVL, VRT, VIAV, KEYS, FN, XE, SMR, POET, AVAV, ORCL, MTSI, ATI, BWX fetched separately (14 tickers). All Scorecard prices from fetch-prices.py.
- Momentum Tripwire: >1.5x 200MA: AXTI (3.38x), AAOI (2.78x), AEHR (2.67x), LITE (2.16x), INTC (2.16x), VIAV (2.13x), RVMD (1.94x), MU (1.86x), AMKR (1.84x), TSEM (1.81x), MRVL (1.76x), COHR (1.74x), AMPX (1.68x), VRT (1.61x), KEYS (1.56x), MTSI (1.47x). All in Momentum Leaders and/or Scorecard with explanations. None silent.
Generated: 2026-04-29 | 60+ sources | Companion: technical | sentiment | alpha